Anyaoku, V.

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism

Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine

Reproductive Health and ContraceptionLipoproteins and Cardiovascular Health

Cited by 417

Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance

Robinson, S., Chan, S., Spacey, S., Anyaoku, V., Johnston, D. G., & Franks, S. (1992) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 141

Response of Sex Hormone Binding Globulin and Insulin-like Growth Factor Binding Protein-1 to an Oral Glucose Tolerance Test in Obese Women with Polycystic Ovary Syndrome before and after Calorie Restriction

Hamilton‐Fairley, D., Kiddy, D., Anyaoku, V., Koistinen, R., Seppälä, M., & Franks, S. (1993) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 75

The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes

Kousta, E., Efstathiadou, Z., Lawrence, N. J., Jeffs, J. A. R., Godsland, I. F., Barrett, S. C., Doré, C. J., Penny, A., Anyaoku, V., Millauer, B. A., et al. (2006) · Diabetologia

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 74

Differential Metabolic Actions of Biosynthetic Insulin Analogues in Normal Man Assessed by Stable Isotopic Tracers

Gelding, S. V., Coldham, N., Anyaoku, V., Heslop, K., Halliday, D., & Johnston, D. G. (1993) · Diabetic Medicine

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 4